Donohue JF - Search Results

1

Indacaterol vs tiotropium in COPD patients classified as GOLD A and B.

Mahler DA, Kerstjens HA, Donohue JF, Buhl R, Lawrence D, Altman P. Mahler DA, et al. Among authors: donohue jf. Respir Med. 2015 Aug;109(8):1031-9. doi: 10.1016/j.rmed.2015.05.012. Epub 2015 May 22. Respir Med. 2015. PMID: 26094050 Free article. Clinical Trial.

2

Efficacy of salmeterol xinafoate in the treatment of COPD.

Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH. Mahler DA, et al. Among authors: donohue jf. Chest. 1999 Apr;115(4):957-65. doi: 10.1378/chest.115.4.957. Chest. 1999. PMID: 10208192 Free article. Clinical Trial.

3

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L. Donohue JF, et al. Chest. 2002 Jul;122(1):47-55. doi: 10.1378/chest.122.1.47. Chest. 2002. PMID: 12114338 Clinical Trial.

4

Tolerance to bronchodilating effects of salmeterol in COPD.

Donohue JF, Menjoge S, Kesten S. Donohue JF, et al. Respir Med. 2003 Sep;97(9):1014-20. doi: 10.1016/s0954-6111(03)00131-8. Respir Med. 2003. PMID: 14509555 Free article. Clinical Trial.

5

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K. Donohue JF, et al. Treat Respir Med. 2004;3(3):173-81. doi: 10.2165/00151829-200403030-00005. Treat Respir Med. 2004. PMID: 15219176 Clinical Trial.

6

Therapeutic responses in asthma and COPD. Bronchodilators.

Donohue JF. Donohue JF. Chest. 2004 Aug;126(2 Suppl):125S-137S; discussion 159S-161S. doi: 10.1378/chest.126.2_suppl_1.125S. Chest. 2004. PMID: 15302773 Review.

7

Still looking for answers in COPD.

Donohue JF. Donohue JF. Lancet. 2005 Apr 30-May 6;365(9470):1518-20. doi: 10.1016/S0140-6736(05)66432-X. Lancet. 2005. PMID: 15866290 No abstract available.

8

Role of bronchodilators in chronic obstructive pulmonary disease.

Weder MM, Donohue JF. Weder MM, et al. Among authors: donohue jf. Semin Respir Crit Care Med. 2005 Apr;26(2):221-34. doi: 10.1055/s-2005-869541. Semin Respir Crit Care Med. 2005. PMID: 16088439 Review.

9

Minimal clinically important differences in COPD lung function.

Donohue JF. Donohue JF. COPD. 2005 Mar;2(1):111-24. doi: 10.1081/copd-200053377. COPD. 2005. PMID: 17136971 Free article. Review.

10

Evaluation of the efficacy and safety of levalbuterol in subjects with COPD.

Donohue JF, Parsey MV, Andrews C, D'Urzo T, Sharma S, Schaefer K, Claus R, Baumgartner RA; Levalbuterol COPD Study Group. Donohue JF, et al. COPD. 2006 Aug;3(3):125-32. doi: 10.1080/15412550600829190. COPD. 2006. PMID: 17240614 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters